All-Atom
Contacts		 Clashscore, all atoms:10.39 88th percentile* (N=456, 2.20Å ± 0.25Å)
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms.
Protein
Geometry		 Poor rotamers113.56% Goal: <1%
Ramachandran outliers30.88% Goal: <0.05%
Ramachandran favored32193.86% Goal: >98%
MolProbity score^2.3662nd percentile* (N=10167, 2.20Å ± 0.25Å)
Cβ deviations >0.25Å00.00% Goal: 0
Bad backbone bonds:0 / 13890.00% Goal: 0%
Bad backbone angles:0 / 17310.00% Goal: <0.1%
In the two column results, the left column gives the raw count, right column gives the percentage.
* 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst. For clashscore the comparative set of structures was selected in 2004, for MolProbity score in 2006.
^ MolProbity score combines the clashscore, rotamer, and Ramachandran evaluations into a single score, normalized to be on the same scale as X-ray resolution.

Live sorting requires JavaScript enabled and Safari 2, Firefox 1.5, or IE 6

#ResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengths.Bond angles.
Avg: 50.32Clashscore: 10.39Outliers: 3 of 342Poor rotamers: 11 of 309Outliers: 0 of 334Outliers: 0 of 348Outliers: 0 of 348
A 45 ASP73.14--0.4%
chi angles: 221.9,68		0.032Å--
A 46 ASN65.43-Favored (47.04%)
General case / -59.5,-19.3		23.4% (t30)
chi angles: 173.5,47		0.022Å--
A 47 GLN53.77-Favored (61.48%)
General case / -72.4,-13.5		25.3% (mt-30)
chi angles: 297.2,166.3,122		0.031Å--
A 48 PHE46.5-Favored (18.27%)
General case / -111.7,159.4		86.1% (m-85)
chi angles: 299.8,86.3		0.054Å--
A 49 TYR48.340.537Å
CE1 with A 51 VAL HG13 		Favored (38.47%)
General case / -145.2,151.5		18% (p90)
chi angles: 78.9,95.9		0.02Å--
A 50 SER54.74-Favored (52.02%)
General case / -106.5,132.9		75.1% (m)
chi angles: 294.7		0.028Å--
A 51 VAL60.20.537Å
HG13 with A 49 TYR CE1 		Favored (28.18%)
Isoleucine or valine / -123.1,146.6		0.1%
chi angles: 270.1		0.052Å--
A 52 GLU75.06-Favored (25.93%)
General case / -82.2,120.9		5% (tp10)
chi angles: 206.4,38,49.5		0.022Å--
A 53 VAL67.280.763Å
HG13 with A 69 PRO HG3 		Favored (2.6%)
Isoleucine or valine / -128.9,95.0		90% (t)
chi angles: 175.3		0.011Å--
A 54 GLY69.39-Favored (29.03%)
Glycine / 64.1,-123.9		----
A 55 ASP75.21-Favored (37.31%)
General case / -96.2,-6.8		12.4% (p-10)
chi angles: 54.9,125.9		0.021Å--
A 56 SER65.09-Favored (12.96%)
General case / -103.5,162.5		7.2% (t)
chi angles: 196.7		0.011Å--
A 57 THR54.21-Favored (48.19%)
General case / -115.5,123.3		99.7% (m)
chi angles: 298.6		0.028Å--
A 58 PHE43.95-Favored (32.83%)
General case / -96.3,118.4		2.5% (m-85)
chi angles: 261.2,61.7		0.08Å--
A 59 THR42.3-Favored (7.45%)
General case / -112.6,98.8		92.1% (m)
chi angles: 300.5		0.065Å--
A 60 VAL41.91-Favored (13.42%)
Isoleucine or valine / -120.6,168.0		2.4% (m)
chi angles: 318.1		0.036Å--
A 61 LEU39.49-Favored (54.1%)
General case / -60.6,143.3		40.1% (mt)
chi angles: 294.4,161.8		0.047Å--
A 62 LYS44.55-Favored (60.61%)
General case / -59.8,-21.2		89.1% (mttt)
chi angles: 283.4,167.7,177.9,179.8		0.093Å--
A 63 ARG39.33-Favored (57.27%)
General case / -62.6,-16.5		17.3% (ptm180)
chi angles: 64.6,184.1,286.6,172.8		0.064Å--
A 64 TYR40.74-Favored (36.74%)
General case / -100.1,118.6		39.1% (m-85)
chi angles: 297.5,124.6		0.016Å--
A 65 GLN56.68-Favored (35.81%)
General case / -127.7,159.1		49.4% (mt-30)
chi angles: 310.8,168.4,6.4		0.041Å--
A 66 ASN52.4-Favored (7.71%)
General case / 57.0,53.7		5.4% (t-20)
chi angles: 194.2,221.2		0.028Å--
A 67 LEU45.530.477Å
HD22 with A 51 VAL HG21 		Favored (54.55%)
General case / -65.5,135.0		9.4% (mp)
chi angles: 269.9,66.9		0.041Å--
A 68 LYS57.93-Favored (14.29%)
Pre-proline / -137.9,126.1		67.2% (mttt)
chi angles: 306.1,200.6,167,189.2		0.035Å--
A 69 PRO47.490.763Å
HG3 with A 53 VAL HG13 		Favored (91.33%)
Trans proline / -59.3,139.8		81.1% (Cg_exo)
chi angles: 330.6,41.7,82.5		0.051Å--
A 70 ILE45.39-Allowed (1.54%)
Isoleucine or valine / -132.7,7.3		26.4% (pt)
chi angles: 56.7,179.7		0.051Å--
A 71 GLY45.59-Favored (6.64%)
Glycine / 145.1,155.9		----
A 72 SER47.49-Favored (44.03%)
General case / -145.6,157.2		83.2% (p)
chi angles: 69.1		0.054Å--
A 73 GLY46.93-Favored (15.7%)
Glycine / -146.6,-171.2		----
A 74 ALA49.32-Favored (73.4%)
General case / -61.6,-33.1		-0.017Å--
A 75 GLN51.06-Favored (37.17%)
General case / -80.5,-29.9		11.4% (tt0)
chi angles: 200.8,206,22		0.047Å--
A 76 GLY47.68-Favored (43.69%)
Glycine / 175.9,175.9		----
A 77 ILE45.2-Favored (28.98%)
Isoleucine or valine / -97.3,136.2		30% (mm)
chi angles: 309.5,306.4		0.079Å--
A 78 VAL36.49-Favored (52.44%)
Isoleucine or valine / -116.8,136.9		59.8% (t)
chi angles: 181		0.011Å--
A 79 CYS44.47-Favored (42.16%)
General case / -126.2,155.2		67.9% (m)
chi angles: 287.9		0.094Å--
A 80 ALA35.7-Favored (22.08%)
General case / -99.5,150.6		-0.107Å--
A 81 ALA35.79-Favored (33.09%)
General case / -160.6,163.0		-0.051Å--
A 82 TYR43.54-Favored (44.86%)
General case / -100.7,123.4		36.4% (t80)
chi angles: 171.9,59.7		0.091Å--
A 83 ASP39.27-Favored (10.22%)
General case / -93.8,97.2		52.7% (t0)
chi angles: 175.7,177.5		0.092Å--
A 84 ALA42.58-Favored (65.39%)
General case / -59.6,-26.4		-0.018Å--
A 85 VAL43.71-Favored (65.52%)
Isoleucine or valine / -72.2,-43.4		18.4% (t)
chi angles: 162.4		0.057Å--
A 86 LEU44.88-Favored (39.65%)
General case / -90.2,-11.9		83% (mt)
chi angles: 289.6,174.6		0.053Å--
A 87 ASP49.7-Favored (3.84%)
General case / 56.9,58.7		23.3% (t0)
chi angles: 182.3,42.7		0.077Å--
A 88 ARG61.33-Favored (8.9%)
General case / -163.0,142.7		72% (ttt180)
chi angles: 175.6,183.4,189,183.6		0.15Å--
A 89 ASN44.71-Favored (33.77%)
General case / -79.6,144.6		44.3% (m-80)
chi angles: 308.1,292.5		0.044Å--
A 90 VAL37.32-Favored (30.86%)
Isoleucine or valine / -136.6,164.5		23% (m)
chi angles: 302.6		0.097Å--
A 91 ALA33.88-Favored (42.35%)
General case / -107.1,138.9		-0.097Å--
A 92 ILE33.42-Favored (49.92%)
Isoleucine or valine / -126.5,118.0		37.6% (mt)
chi angles: 298.7,185.2		0.056Å--
A 93 LYS40.39-Favored (53.89%)
General case / -105.7,129.6		38.2% (ttpt)
chi angles: 175.5,165,66.1,172.5		0.032Å--
A 94 LYS40.9-Favored (48.41%)
General case / -101.6,126.4		77.1% (tttt)
chi angles: 175.8,195.7,180,179.3		0.021Å--
A 95 LEU36.46-Favored (33.09%)
General case / -105.7,117.1		73.4% (mt)
chi angles: 299.1,183.5		0.073Å--
A 96 SER44.66-Favored (26.2%)
General case / -93.6,114.0		53.5% (m)
chi angles: 299.9		0.113Å--
A 97 ARG41-Favored (6.81%)
Pre-proline / 45.3,65.1		70.9% (mtp85)
chi angles: 298.3,188,69.5,84.3		0.039Å--
A 98 PRO39.5-Favored (77.75%)
Trans proline / -56.1,-30.2		14.1% (Cg_exo)
chi angles: 347.7,25.7,92.1		0.034Å--
A 99 PHE41.8-Favored (17.86%)
General case / -80.0,4.2		18.2% (p90)
chi angles: 49.1,78.8		0.037Å--
A 100 GLN44.44-Favored (68.29%)
General case / -59.3,-30.4		8.7% (pt20)
chi angles: 70.2,184.3,264.2		0.095Å--
A 101 ASN45.9-Favored (30.99%)
General case / -150.3,166.1		18.4% (p30)
chi angles: 67.8,50.4		0.118Å--
A 102 GLN59.38-Favored (73.58%)
General case / -54.9,-44.0		2.8% (tp-100)
chi angles: 203.3,75.6,193.7		0.043Å--
A 103 THR49.18-Favored (35.51%)
General case / -60.0,-55.3		51.2% (m)
chi angles: 304.8		0.039Å--
A 104 HIS54.55-Favored (82.96%)
General case / -66.5,-36.6		41.8% (m-70)
chi angles: 282.4,309.6		0.066Å--
A 105 ALA42.28-Favored (70.02%)
General case / -66.5,-48.4		-0.05Å--
A 106 LYS55.3-Favored (76.96%)
General case / -57.9,-49.4		22.9% (tptm)
chi angles: 189.3,67.5,171.7,302.1		0.052Å--
A 107 ARG50.52-Favored (81.2%)
General case / -60.7,-48.6		72.6% (ttt180)
chi angles: 175.6,167.5,173.2,181.9		0.041Å--
A 108 ALA42.24-Favored (98.65%)
General case / -61.3,-43.6		-0.011Å--
A 109 TYR57.42-Favored (32.09%)
General case / -67.0,-53.4		84.6% (t80)
chi angles: 175.1,82.5		0.021Å--
A 110 ARG61.820.927Å
CZ with A 211 ALA HB2 		Favored (69.95%)
General case / -54.9,-40.7		32.1% (ttt-85)
chi angles: 174.3,151.4,169.9,285.7		0.024Å--
A 111 GLU51.74-Favored (84.06%)
General case / -66.2,-44.4		89.6% (mt-10)
chi angles: 290.4,182.9,153.4		0.033Å--
A 112 LEU52.39-Favored (77.04%)
General case / -55.8,-47.4		4.1% (mt)
chi angles: 265.7,156.6		0.05Å--
A 113 VAL53.34-Allowed (1.29%)
Isoleucine or valine / -65.2,-62.3		53% (t)
chi angles: 170.5		0.041Å--
A 114 LEU54.870.423Å
C with A 116 LYS H 		Favored (51.22%)
General case / -50.4,-41.2		67.5% (mt)
chi angles: 296.7,184.3		0.02Å--
A 115 MET61.14-Allowed (0.22%)
General case / -57.3,-4.4		7.8% (mtm)
chi angles: 269.8,177,321.6		0.039Å--
A 116 LYS70.540.423Å
H with A 114 LEU C 		Favored (11.32%)
General case / -116.2,-11.4		84.1% (mttt)
chi angles: 305.8,177.4,176.3,193.1		0.047Å--
A 117 CYS75.730.465Å
O with A 373 PRO HB2 		Favored (17.72%)
General case / -102.9,20.3		55.6% (m)
chi angles: 284.5		0.054Å--
A 118 VAL63.36-Favored (20.16%)
Isoleucine or valine / -143.6,147.3		34.1% (m)
chi angles: 299.1		0.025Å--
A 119 ASN59.81-Allowed (1.39%)
General case / -150.2,85.3		36.2% (t30)
chi angles: 176.4,54.1		0.055Å--
A 120 HIS51.28-Favored (15.79%)
General case / -151.3,134.2		62.7% (t-80)
chi angles: 190.8,288.6		0.067Å--
A 121 LYS50.04-Favored (32.47%)
General case / -60.8,-15.7		61.5% (pttt)
chi angles: 58.3,175.8,175.9,182.9		0.025Å--
A 122 ASN37.46-Favored (47.86%)
General case / -98.7,5.2		28.4% (m120)
chi angles: 298.7,130.7		0.101Å--
A 123 ILE35.63-Favored (50.39%)
Isoleucine or valine / -121.3,138.8		47% (mm)
chi angles: 298.7,299.5		0.12Å--
A 124 ILE40.94-Allowed (0.44%)
Isoleucine or valine / -43.2,142.8		6.2% (tt)
chi angles: 176.3,182.2		0.036Å--
A 125 SER45.840.41Å
HB2 with A 629 HOH O 		Favored (30.8%)
General case / -135.6,128.2		46.3% (t)
chi angles: 180.5		0.189Å--
A 126 LEU40.73-Favored (33.08%)
General case / -85.6,137.1		19.1% (mt)
chi angles: 290.5,192.2		0.077Å--
A 127 LEU37.66-Favored (15.84%)
General case / -92.4,-30.3		0%
chi angles: 257.5,15.4		0.085Å--
A 128 ASN36.58-Favored (15%)
General case / -166.7,160.7		24.9% (t-20)
chi angles: 202.8,4.7		0.094Å--
A 129 VAL40.63-Favored (6.75%)
Isoleucine or valine / -151.7,134.4		2.6% (p)
chi angles: 49.6		0.043Å--
A 130 PHE36.68-Favored (31.94%)
General case / -160.2,165.2		45.9% (p90)
chi angles: 62.4,84.2		0.063Å--
A 131 THR38.86-Favored (28.19%)
Pre-proline / -133.2,136.9		1.7% (t)
chi angles: 168.5		0.092Å--
A 132 PRO45.67-Favored (24.58%)
Trans proline / -72.3,-20.4		32% (Cg_exo)
chi angles: 339.6,39.4,77.7		0.04Å--
A 133 GLN49.80.438Å
HG2 with A 138 GLU O 		Favored (37.51%)
General case / -78.6,136.4		21.4% (mp0)
chi angles: 295.6,85.7,42.5		0.073Å--
A 134 LYS64.76-Favored (35.41%)
General case / -80.8,-32.3		78.8% (mttt)
chi angles: 311.2,168.5,178.9,179.6		0.013Å--
A 135 THR58.30.533Å
OG1 with A 138 GLU HG3 		Favored (40.82%)
General case / -124.4,154.1		72.6% (p)
chi angles: 63.6		0.077Å--
A 136 LEU60.12-Favored (68.18%)
General case / -56.0,-36.8		18.5% (tp)
chi angles: 163.8,60.7		0.062Å--
A 137 GLU68.35-Favored (94.07%)
General case / -63.8,-39.4		4.2% (tp10)
chi angles: 216.5,46.4,40.5		0.015Å--
A 138 GLU57.90.533Å
HG3 with A 135 THR OG1 		Favored (45.84%)
General case / -87.8,-12.2		21.3% (mt-10)
chi angles: 314,174.8,72.8		0.038Å--
A 139 PHE47.51-Favored (7.06%)
General case / -48.5,123.7		31.6% (t80)
chi angles: 179.5,53.2		0.034Å--
A 140 GLN53.65-Allowed (0.78%)
General case / -134.1,-45.7		51.1% (mt-30)
chi angles: 294.6,198.6,57.5		0.026Å--
A 141 ASP40.8-Favored (36.72%)
General case / -117.2,151.5		53.5% (m-20)
chi angles: 304.6,127		0.049Å--
A 142 VAL35.15-Favored (70.05%)
Isoleucine or valine / -126.8,132.5		84.8% (t)
chi angles: 174.9		0.078Å--
A 143 TYR33.2-Favored (56.42%)
General case / -114.8,128.7		94.5% (m-85)
chi angles: 292.8,87		0.011Å--
A 144 LEU32.75-Favored (52.11%)
General case / -116.3,137.5		87.7% (mt)
chi angles: 299.1,180.1		0.053Å--
A 145 VAL31.01-Favored (68.59%)
Isoleucine or valine / -125.0,133.8		49.5% (t)
chi angles: 182.5		0.032Å--
A 146 MET33.09-Favored (14.25%)
General case / -143.4,171.4		28.3% (ptm)
chi angles: 68.8,176.5,288.3		0.051Å--
A 147 GLU47.920.588Å
HG2 with A 624 HOH O 		Favored (46.92%)
General case / -54.9,136.3		45.3% (tt0)
chi angles: 194.8,187.5,148.6		0.14Å--
A 148 LEU34.11-Favored (25.84%)
General case / -78.7,122.3		43.1% (tp)
chi angles: 178.9,69.7		0.049Å--
A 149 MET37.79-Favored (13.6%)
General case / -96.3,162.2		84.7% (mmm)
chi angles: 304.3,293.9,280.7		0.038Å--
A 150 ASP39.75-Favored (25.85%)
General case / -84.5,-29.7		67% (m-20)
chi angles: 298.4,125.9		0.065Å--
A 151 ALA35.12-Favored (19.58%)
General case / -164.7,166.8		-0.079Å--
A 152 ASN38.14-Favored (6.23%)
General case / -101.2,173.9		34.4% (p30)
chi angles: 57.5,29		0.082Å--
A 153 LEU35.86-Favored (63.05%)
General case / -70.2,-24.0		7.6% (tp)
chi angles: 205.8,44.5		0.026Å--
A 154 CYS42.55-Favored (88.04%)
General case / -58.4,-42.8		93.5% (m)
chi angles: 290		0.066Å--
A 155 GLN46.07-Favored (75.1%)
General case / -68.6,-44.0		78.9% (mt-30)
chi angles: 299.6,174.7,294.5		0.037Å--
A 156 VAL41.350.595Å
CG1 with A 161 LEU HD11 		Favored (53.87%)
Isoleucine or valine / -60.7,-33.2		54.6% (t)
chi angles: 170		0.03Å--
A 157 ILE42.73-Favored (57.05%)
Isoleucine or valine / -63.5,-32.5		2% (mt)
chi angles: 267.2,166.6		0.045Å--
A 158 GLN54.43-Favored (46.21%)
General case / -75.8,-5.5		67.7% (mt-30)
chi angles: 279.2,179,292.5		0.034Å--
A 159 MET54.33-Favored (11.67%)
General case / -115.1,166.6		13.2% (ptp)
chi angles: 59.8,198.1,58		0.029Å--
A 160 GLU46.5-Favored (33.66%)
General case / -86.8,133.1		93.3% (mt-10)
chi angles: 291.3,188.4,167.6		0.121Å--
A 161 LEU46.10.595Å
HD11 with A 156 VAL CG1 		Favored (36.85%)
General case / -116.0,150.7		34.5% (mt)
chi angles: 296.7,161.9		0.062Å--
A 162 ASP53.11-Favored (12.81%)
General case / -82.8,172.5		8.9% (p-10)
chi angles: 57.3,109.6		0.131Å--
A 163 HIS43.25-Favored (69.33%)
General case / -68.8,-30.7		93.7% (m-70)
chi angles: 290.8,282.9		0.069Å--
A 164 GLU59.070.474Å
HG2 with A 362 TRP CZ2 		Favored (77.1%)
General case / -62.2,-49.1		7.6% (tt0)
chi angles: 191.9,208.8,70.5		0.072Å--
A 165 ARG58.69-Favored (63.07%)
General case / -70.5,-46.8		73.2% (mtt85)
chi angles: 291.8,181.7,178.8,70.5		0.061Å--
A 166 MET50.10.593Å
HG3 with A 256 MET CE 		Favored (72.9%)
General case / -58.1,-50.6		38.1% (ttm)
chi angles: 193.3,169.5,274.2		0.043Å--
A 167 SER35.84-Favored (96.59%)
General case / -61.1,-41.4		32.8% (p)
chi angles: 77.1		0.056Å--
A 168 TYR37.63-Favored (87.78%)
General case / -61.6,-46.9		16.6% (t80)
chi angles: 187.1,47.2		0.037Å--
A 169 LEU34.83-Favored (72.98%)
General case / -56.5,-50.0		88.9% (mt)
chi angles: 297.7,171.8		0.029Å--
A 170 LEU33.41-Favored (94.51%)
General case / -60.1,-45.0		78.9% (mt)
chi angles: 291.8,166.9		0.049Å--
A 171 TYR40.9-Favored (70.3%)
General case / -54.0,-43.8		33.1% (t80)
chi angles: 164.6,68.4		0.055Å--
A 172 GLN33.43-Favored (76.29%)
General case / -69.8,-39.6		49.1% (mt-30)
chi angles: 291.3,174.7,89.2		0.038Å--
A 173 MET37.01-Favored (85.27%)
General case / -57.7,-43.8		13.9% (mtt)
chi angles: 291.7,172.3,236.3		0.054Å--
A 174 LEU35.65-Favored (91.99%)
General case / -63.5,-38.7		56.9% (mt)
chi angles: 290.5,163.9		0.054Å--
A 175 CYS42.78-Favored (69.23%)
General case / -63.2,-50.7		69.6% (m)
chi angles: 288.4		0.061Å--
A 176 GLY37.55-Favored (59.97%)
Glycine / -53.5,-48.7		----
A 177 ILE38.98-Favored (97.01%)
Isoleucine or valine / -63.9,-45.4		56.2% (mt)
chi angles: 292.8,158.1		0.023Å--
A 178 LYS51.61-Favored (72.08%)
General case / -54.2,-45.2		48.5% (tptt)
chi angles: 168.1,69.1,169.3,169.1		0.082Å--
A 179 HIS49.330.489Å
CE1 with A 373 PRO HD3 		Favored (92.43%)
General case / -61.3,-45.9		64% (t60)
chi angles: 193.8,65.1		0.019Å--
A 180 LEU44.01-Favored (90.73%)
General case / -58.8,-44.4		30.1% (mt)
chi angles: 291.2,188.5		0.019Å--
A 181 HIS46.42-Favored (85.25%)
General case / -61.0,-38.2		62.3% (m170)
chi angles: 290.8,172.5		0.032Å--
A 182 SER52.07-Favored (70.9%)
General case / -61.0,-31.3		78.6% (p)
chi angles: 70.1		0.046Å--
A 183 ALA51.01-Favored (10.97%)
General case / -95.6,19.5		-0.035Å--
A 184 GLY47.79-Favored (78.89%)
Glycine / 73.3,15.3		----
A 185 ILE42.81-Favored (36.66%)
Isoleucine or valine / -99.5,114.1		74.1% (mt)
chi angles: 301.9,168		0.037Å--
A 186 ILE43.39-Favored (23.48%)
Isoleucine or valine / -110.5,107.7		72.5% (mt)
chi angles: 303.5,172.6		0.056Å--
A 187 HIS35.06-Allowed (1.34%)
General case / -53.0,-62.9		36% (t-80)
chi angles: 203.4,290.6		0.059Å--
A 188 ARG50.430.421Å
HG2 with A 244 VAL HG11 		Favored (2.24%)
General case / 69.0,-0.9		69.7% (mtm180)
chi angles: 288,189.4,292,157.1		0.08Å--
A 189 ASP42.9-Allowed (1.42%)
General case / -142.9,36.4		30.4% (t0)
chi angles: 196.6,28.4		0.044Å--
A 190 LEU37.91-Favored (58.34%)
General case / -65.7,139.1		16.8% (mt)
chi angles: 288.6,154.1		0.104Å--
A 191 LYS48.28-Favored (34.73%)
Pre-proline / -151.2,155.5		16% (ptpt)
chi angles: 64.8,189.7,76.1,179.7		0.028Å--
A 192 PRO30.830.442Å
HD2 with A 613 HOH O 		Favored (98.67%)
Trans proline / -57.7,-35.8		14.6% (Cg_exo)
chi angles: 347.5,26.2,91		0.069Å--
A 193 SER33.79-Favored (65.76%)
General case / -65.6,-19.0		86.8% (p)
chi angles: 61.4		0.075Å--
A 194 ASN35.44-Favored (17.11%)
General case / -102.3,20.3		73.5% (m-20)
chi angles: 280.8,325.3		0.056Å--
A 195 ILE31.38-Favored (68.62%)
Isoleucine or valine / -128.8,130.1		64.2% (mt)
chi angles: 300.6,163.3		0.085Å--
A 196 VAL32.4-Favored (23.97%)
Isoleucine or valine / -120.7,155.9		5.1% (m)
chi angles: 284.9		0.023Å--
A 197 VAL37.88-Favored (41.91%)
Isoleucine or valine / -134.1,157.6		5.6% (m)
chi angles: 310.3		0.054Å--
A 198 LYS51.99-Favored (12.44%)
General case / -109.4,164.5		39.1% (mtmt)
chi angles: 279.6,205.9,292.6,186.3		0.061Å--
A 199 SER51.46-Favored (45.65%)
General case / -51.9,-35.5		1.2% (m)
chi angles: 267.3		0.027Å--
A 200 ASP47.59-Favored (3.5%)
General case / -83.3,14.6		58% (p30)
chi angles: 63.8,0.9		0.023Å--
A 201 CYS54.04-Favored (3.78%)
General case / 75.7,2.7		0.1%
chi angles: 233.6		0.083Å--
A 202 THR44.04-Favored (47.62%)
General case / -68.5,150.8		40.8% (p)
chi angles: 54		0.034Å--
A 203 LEU35.710.5Å
C with A 203 LEU HD23 		Favored (48.18%)
General case / -136.2,148.5		2.6% (tt)
chi angles: 168.3,161.3		0.055Å--
A 204 LYS36.58-Favored (37.06%)
General case / -138.8,137.8		59% (mttm)
chi angles: 304.4,180,180.1,283.7		0.034Å--
A 205 ILE33.07-Favored (40.78%)
Isoleucine or valine / -86.7,126.6		80.6% (mt)
chi angles: 294.5,176.1		0.109Å--
A 206 LEU32.61-Favored (34.07%)
General case / -84.6,-18.9		68.3% (mt)
chi angles: 300.6,170.5		0.049Å--
A 207 ASP34.57-Favored (7.29%)
General case / -132.7,177.9		7.9% (p-10)
chi angles: 73.3,131.1		0.057Å--
A 208 PHE39-Favored (16.46%)
General case / -115.2,11.9		68.4% (m-85)
chi angles: 302.8,83		0.101Å--
A 209 GLY46.37-Favored (33.08%)
Glycine / 80.2,-151.4		----
A 210 LEU57.59-Favored (13.71%)
General case / -83.7,-45.2		54% (mt)
chi angles: 307.2,181.6		0.038Å--
A 211 ALA65.060.927Å
HB2 with A 110 ARG CZ 		Allowed (0.18%)
General case / 64.3,171.7		-0.016Å--
A 212 ARG68.9---0.02Å--
A 217 SER80.5--6.3% (p)
chi angles: 44.3		0.016Å--
A 218 PHE80.31-Favored (26.11%)
General case / -89.1,144.5		34.1% (t80)
chi angles: 163.4,74.7		0.044Å--
A 219 MET85.89-Favored (38.3%)
General case / -139.0,141.0		38.3% (ttm)
chi angles: 191.6,165.3,279		0.01Å--
A 220 MET84.96-Favored (2.38%)
General case / -90.6,25.2		2.6% (mmt)
chi angles: 274.2,280.8,216.4		0.023Å--
A 221 THR86.84-Favored (38.83%)
Pre-proline / -108.2,156.2		48.5% (p)
chi angles: 55.6		0.023Å--
A 222 PRO86.53-Favored (26.56%)
Trans proline / -70.4,-9.8		85.4% (Cg_exo)
chi angles: 331.1,43.7,78.9		0.011Å--
A 223 TYR85.75-Favored (54.49%)
General case / -68.5,137.5		42.7% (m-85)
chi angles: 292.2,74		0.023Å--
A 224 VAL77.12-Favored (67.03%)
Isoleucine or valine / -115.6,121.3		21.7% (t)
chi angles: 187.9		0.04Å--
A 225 VAL67.49-Favored (20.2%)
Isoleucine or valine / -62.0,139.8		69.9% (t)
chi angles: 173.4		0.051Å--
A 226 THR55.130.52Å
OG1 with A 502 ANP H5'2 		Favored (21.35%)
General case / -80.7,117.5		84.4% (m)
chi angles: 297.5		0.101Å--
A 227 ARG61.02-Favored (15.89%)
General case / -108.3,-7.5		46.2% (mtt85)
chi angles: 304.7,205.4,178.4,75.7		0.034Å--
A 228 TYR52.95-Allowed (0.69%)
General case / -43.9,-30.5		6.9% (m-85)
chi angles: 314.1,138.9		0.028Å--
A 229 TYR35.860.477Å
OH with A 502 ANP N6 		Favored (38.33%)
General case / -102.2,3.3		17.9% (m-85)
chi angles: 313.3,87.5		0.04Å--
A 230 ARG42.01-Favored (37.66%)
General case / -78.1,135.0		96.2% (mtt180)
chi angles: 289.7,180.6,191.1,184.7		0.055Å--
A 231 ALA39.24-Favored (89.15%)
Pre-proline / -64.6,152.7		-0.02Å--
A 232 PRO41.3-Favored (21.56%)
Trans proline / -51.5,-48.4		38.1% (Cg_exo)
chi angles: 325.8,42.9,85.3		0.045Å--
A 233 GLU42.95-Favored (65.49%)
General case / -60.0,-25.6		8.2% (pm0)
chi angles: 56.7,268.2,49.7		0.08Å--
A 234 VAL47.03-Favored (9.71%)
Isoleucine or valine / -86.7,-36.1		85.9% (t)
chi angles: 175		0.045Å--
A 235 ILE51.29-Favored (36.85%)
Isoleucine or valine / -69.3,-28.0		82.2% (mt)
chi angles: 289.8,167.8		0.083Å--
A 236 LEU53.84-Favored (37.25%)
General case / -103.7,6.9		73.4% (mt)
chi angles: 303.6,175.5		0.038Å--
A 237 GLY54.27-Favored (58.36%)
Glycine / 58.7,51.5		----
A 238 MET63.370.564Å
HG2 with A 239 GLY N 		Favored (4.04%)
General case / -110.4,179.6		1.5% (ttm)
chi angles: 168.6,185.2,342.1		0.109Å--
A 239 GLY52.470.564Å
N with A 238 MET HG2 		Favored (51.34%)
Glycine / -74.1,172.7		----
A 240 TYR51.49-Favored (39.83%)
General case / -156.7,161.8		22% (p90)
chi angles: 63.4,76.5		0.034Å--
A 241 LYS53.96-Favored (2.36%)
General case / -130.5,-170.6		34.1% (pttt)
chi angles: 42.5,172.9,180.5,167.7		0.012Å--
A 242 GLU51.920.429Å
OE1 with A 242 GLU N 		Favored (61.55%)
General case / -51.4,-42.6		31.8% (mp0)
chi angles: 284.2,73.1,169.5		0.024Å--
A 243 ASN39.96-Allowed (1.15%)
General case / -66.4,2.7		21.5% (p-10)
chi angles: 79.3,353		0.174Å--
A 244 VAL37.230.421Å
HG11 with A 188 ARG HG2 		Favored (48.35%)
Isoleucine or valine / -61.0,-30.8		11.9% (p)
chi angles: 66.2		0.049Å--
A 245 ASP35.82-Favored (60.23%)
General case / -73.4,-23.9		69.2% (m-20)
chi angles: 287.8,141.2		0.05Å--
A 246 ILE32.20.577Å
HD11 with A 350 VAL HA 		Favored (82.6%)
Isoleucine or valine / -62.2,-39.1		13.7% (mm)
chi angles: 284.4,291.9		0.037Å--
A 247 TRP33.04-Favored (87.56%)
General case / -58.4,-42.6		36.2% (t-105)
chi angles: 175.6,274.5		0.032Å--
A 248 SER32.12-Favored (88.21%)
General case / -64.7,-37.6		50.9% (m)
chi angles: 301.5		0.048Å--
A 249 VAL30.94-Favored (85.21%)
Isoleucine or valine / -66.1,-39.8		53.5% (t)
chi angles: 170.3		0.015Å--
A 250 GLY29.81-Favored (96.42%)
Glycine / -59.2,-44.5		----
A 251 CYS31.83-Favored (86.31%)
General case / -61.4,-38.2		94.3% (m)
chi angles: 293.8		0.035Å--
A 252 ILE32.35-Favored (67.94%)
Isoleucine or valine / -70.0,-47.6		72.4% (mt)
chi angles: 291.2,176.2		0.079Å--
A 253 MET36.55-Favored (86.72%)
General case / -59.6,-47.1		13.3% (ttt)
chi angles: 166.3,166.5,193.5		0.045Å--
A 254 GLY40.36-Favored (92.77%)
Glycine / -61.1,-36.7		----
A 255 GLU42.69-Favored (68.36%)
General case / -69.4,-30.4		51.5% (tt0)
chi angles: 187.8,170.4,145.5		0.027Å--
A 256 MET53.130.593Å
CE with A 166 MET HG3 		Favored (67.02%)
General case / -68.9,-28.8		72.3% (mtp)
chi angles: 279.1,165,70.1		0.026Å--
A 257 VAL46.64-Favored (17.26%)
Isoleucine or valine / -85.4,-45.8		98.2% (t)
chi angles: 176.3		0.054Å--
A 258 ARG48.26-Favored (44.85%)
General case / -80.2,-20.4		76.4% (mtt180)
chi angles: 291.5,199.6,177.5,164		0.109Å--
A 259 HIS50.45-Favored (13.45%)
General case / 64.3,25.0		97% (m-70)
chi angles: 299.4,293.9		0.043Å--
A 260 LYS62.49-Favored (21.22%)
General case / -152.8,141.8		52.9% (mtmt)
chi angles: 289.7,190.4,299.8,181.7		0.024Å--
A 261 ILE46.4-Favored (14.89%)
Isoleucine or valine / -53.2,130.7		85.3% (mt)
chi angles: 297.9,166		0.057Å--
A 262 LEU43.69-Favored (54.84%)
General case / -67.7,-51.0		19% (mt)
chi angles: 293.6,193.6		0.041Å--
A 263 PHE48.83-Favored (40.33%)
Pre-proline / -121.8,78.7		22.1% (m-85)
chi angles: 314.6,117.5		0.048Å--
A 264 PRO57.66-Favored (9.44%)
Trans proline / -74.7,125.4		12.5% (Cg_exo)
chi angles: 348.6,31.3,81.7		0.073Å--
A 265 GLY60.93-Favored (5.44%)
Glycine / -151.9,136.4		----
A 266 ARG73.87-Favored (56.02%)
General case / -76.2,-26.2		10.5% (ptt180)
chi angles: 31.7,164.2,178.8,173.6		0.026Å--
A 267 ASP65.480.416Å
OD2 with A 269 ILE HB 		Favored (14.86%)
General case / -147.9,172.0		2.6% (p-10)
chi angles: 49.5,91.3		0.036Å--
A 268 TYR69.53-Favored (82.72%)
General case / -57.3,-46.9		3.8% (m-85)
chi angles: 276.8,141.4		0.038Å--
A 269 ILE60.490.439Å
HG23 with A 297 TYR OH 		Favored (6.61%)
Isoleucine or valine / -51.1,-55.8		30.8% (mm)
chi angles: 294.9,292.7		0.052Å--
A 270 ASP57.19-Favored (86.55%)
General case / -58.8,-41.4		26.1% (t0)
chi angles: 189,39.4		0.051Å--
A 271 GLN56.25-Favored (65.61%)
General case / -56.7,-52.3		53.8% (tp60)
chi angles: 185.9,78.8,43.3		0.08Å--
A 272 TRP49.01-Favored (78.89%)
General case / -59.7,-37.4		71% (t-105)
chi angles: 182.7,245.2		0.032Å--
A 273 ASN50.52-Favored (83.49%)
General case / -66.0,-36.5		91.1% (m-20)
chi angles: 293.2,321.9		0.086Å--
A 274 LYS55.81-Favored (75.9%)
General case / -67.6,-33.9		40.8% (mmtm)
chi angles: 298.9,295.8,202.2,304.3		0.009Å--
A 275 VAL46.41-Favored (28.51%)
Isoleucine or valine / -67.0,-54.0		73.3% (t)
chi angles: 172		0.022Å--
A 276 ILE49.17-Favored (80.82%)
Isoleucine or valine / -63.5,-37.9		47.3% (pt)
chi angles: 63.3,171.1		0.085Å--
A 277 GLU58.270.464Å
HG2 with A 304 TYR CZ 		Favored (64.99%)
General case / -58.5,-28.1		90.7% (mt-10)
chi angles: 286.8,171.3,6.3		0.03Å--
A 278 GLN51.3-Favored (5.62%)
General case / -102.7,-43.3		68.9% (mt-30)
chi angles: 294.2,173.1,63.8		0.051Å--
A 279 LEU49.07-Favored (20.79%)
General case / -94.7,-19.0		48.4% (mt)
chi angles: 308.2,181.8		0.03Å--
A 280 GLY47.79-Favored (36.46%)
Glycine / 94.4,166.2		----
A 281 THR50.250.426Å
HA with A 282 PRO HD3 		Favored (96.8%)
Pre-proline / -63.7,136.6		8.5% (m)
chi angles: 314		0.079Å--
A 282 PRO52.940.426Å
HD3 with A 281 THR HA 		Favored (24.11%)
Trans proline / -66.3,165.6		31.7% (Cg_exo)
chi angles: 339.1,37.3,81.7		0.048Å--
A 283 CYS61.40.548Å
SG with A 346 LYS NZ 		Favored (16.62%)
Pre-proline / -67.5,167.2		28.1% (p)
chi angles: 60.8		0.047Å--
A 284 PRO58.79-Favored (28.61%)
Trans proline / -66.8,-35.0		82.3% (Cg_exo)
chi angles: 328.6,45.5,78.1		0.009Å--
A 285 GLU59.190.496Å
O with A 288 LYS HB2 		Favored (81.9%)
General case / -56.8,-45.6		-0.045Å--
A 286 PHE56.64-Favored (70%)
General case / -55.5,-50.4		88.8% (t80)
chi angles: 175.2,77.2		0.05Å--
A 287 MET63.28-Favored (68.05%)
General case / -54.4,-40.2		5.4% (mmt)
chi angles: 312.3,294.1,213.5		0.057Å--
A 288 LYS69.150.496Å
HB2 with A 285 GLU O 		Favored (33.17%)
General case / -54.8,-26.1		58.3% (mttm)
chi angles: 284.6,193.8,188.4,290.3		0.015Å--
A 289 LYS65.48-Favored (57.78%)
General case / -89.2,-5.3		57.1% (mtmt)
chi angles: 295.2,179.9,291.5,182.4		0.067Å--
A 290 LEU64.510.548Å
HB2 with A 295 ARG HB2 		Favored (33.28%)
General case / -82.5,140.6		81.8% (mt)
chi angles: 293,179.5		0.049Å--
A 291 GLN70.110.83Å
HG2 with A 292 PRO HD2 		Favored (65.26%)
Pre-proline / -56.6,144.4		0.9%
chi angles: 200.1,229.5,294.5		0.077Å--
A 292 PRO62.920.83Å
HD2 with A 291 GLN HG2 		Allowed (1.66%)
Trans proline / -37.7,-52.4		21.4% (Cg_exo)
chi angles: 324.3,43.5,86.1		0.082Å--
A 293 THR64.59-Favored (66.45%)
General case / -73.2,-36.5		15.1% (p)
chi angles: 75.7		0.031Å--
A 294 VAL65.15-Favored (76.89%)
Isoleucine or valine / -71.0,-41.0		4.7% (t)
chi angles: 195		0.037Å--
A 295 ARG74.360.575Å
O with A 299 GLU HB2 		Favored (67.69%)
General case / -62.9,-24.2		66.3% (ttt180)
chi angles: 170.4,177.4,186.3,171.1		0.019Å--
A 296 ASN67.87-Favored (38.98%)
General case / -74.5,-46.6		14.9% (t-20)
chi angles: 176.4,290.3		0.064Å--
A 297 TYR64.850.439Å
OH with A 269 ILE HG23 		Favored (86%)
General case / -62.7,-46.9		58.4% (t80)
chi angles: 169.8,70.9		0.057Å--
A 298 VAL66.28-Favored (79.79%)
Isoleucine or valine / -69.9,-42.8		74.3% (t)
chi angles: 173		0.044Å--
A 299 GLU73.980.575Å
HB2 with A 295 ARG O 		Favored (61.2%)
General case / -73.7,-16.3		6.1% (tt0)
chi angles: 214.9,170.9,48.1		0.015Å--
A 300 ASN73.63-Favored (19.26%)
General case / -106.9,20.3		5.8% (m120)
chi angles: 276.5,79.4		0.021Å--
A 301 ARG74.710.411Å
HH11 with A 301 ARG HG3 		Favored (36.25%)
Pre-proline / -94.3,158.2		0%
chi angles: 235.4,42.1,182.8,60.4		0.04Å--
A 302 PRO65-Allowed (1.67%)
Trans proline / -54.5,114.1		72.9% (Cg_exo)
chi angles: 328,42.9,83.5		0.037Å--
A 303 LYS63.4-Favored (20.14%)
General case / -62.5,157.5		13.7% (mptt)
chi angles: 280.8,68.8,173.9,186.1		0.056Å--
A 304 TYR67.330.464Å
CZ with A 277 GLU HG2 		Favored (20.55%)
General case / -146.5,133.7		30.2% (m-85)
chi angles: 277.5,103.2		0.046Å--
A 305 ALA56.03-Favored (80.98%)
General case / -67.8,-36.8		-0.044Å--
A 306 GLY53.65-Favored (25.04%)
Glycine / 89.9,151.3		----
A 307 LEU54.990.552Å
CD1 with A 307 LEU N 		Favored (25.01%)
General case / -94.7,145.2		0.9%
chi angles: 289.2,37.3		0.039Å--
A 308 THR52.77-Favored (35.68%)
General case / -74.0,157.7		12.2% (p)
chi angles: 76.5		0.063Å--
A 309 PHE53.530.439Å
CE2 with A 337 SER HA 		Favored (47.89%)
Pre-proline / -60.1,-37.4		28% (m-85)
chi angles: 277.7,76.1		0.18Å--
A 310 PRO55.09-Favored (98.62%)
Trans proline / -58.2,-35.5		27.8% (Cg_exo)
chi angles: 324.9,42,87.8		0.029Å--
A 311 LYS63.69-Favored (53.1%)
General case / -76.0,-40.9		19.8% (mttp)
chi angles: 257.2,185.3,180.6,59		0.047Å--
A 312 LEU55.68-Favored (94.05%)
General case / -61.1,-40.5		52.4% (mt)
chi angles: 290.6,163.1		0.025Å--
A 313 PHE55.010.512Å
CE2 with A 336 LEU HD13 		Favored (77.15%)
Pre-proline / -127.2,74.3		69.9% (m-85)
chi angles: 301.9,110.6		0.056Å--
A 314 PRO58.33-Favored (5.03%)
Trans proline / -53.1,159.8		87% (Cg_exo)
chi angles: 330.1,42.3,81.7		0.045Å--
A 315 ASP66.13-Favored (65.27%)
General case / -55.9,-34.2		71.2% (m-20)
chi angles: 298.7,133.4		0.049Å--
A 316 SER63.01-Favored (9.31%)
General case / -47.3,-36.4		0.7%
chi angles: 329.9		0.061Å--
A 317 LEU61.44-Favored (60.55%)
General case / -74.7,-12.9		84.6% (mt)
chi angles: 302.1,176.7		0.028Å--
A 318 PHE66.910.511Å
O with A 320 ALA N 		Favored (35.56%)
Pre-proline / -118.3,89.3		97.7% (m-85)
chi angles: 294.6,95.7		0.071Å--
A 319 PRO69.43-Allowed (0.28%)
Trans proline / -64.8,60.4		73.8% (Cg_exo)
chi angles: 332.9,43.5,77.8		0.02Å--
A 320 ALA68.20.558Å
HB1 with A 326 LYS CG 		OUTLIER (0.02%)
General case / -60.0,90.5		-0.03Å--
A 321 ASP64.69-Favored (12.47%)
General case / -89.2,-41.1		3.5% (p-10)
chi angles: 44.3,127.3		0.053Å--
A 322 SER56.63-Favored (8.69%)
General case / -110.6,169.5		62.7% (p)
chi angles: 71.3		0.013Å--
A 323 GLU49.53-Favored (80.01%)
General case / -60.6,-37.0		75.2% (mm-40)
chi angles: 290.3,300.9,156.6		0.022Å--
A 324 HIS51.27-Favored (59.04%)
General case / -56.9,-53.4		82.6% (t60)
chi angles: 175.5,78.3		0.054Å--
A 325 ASN47.47-Favored (74.3%)
General case / -65.7,-32.6		95.9% (m-20)
chi angles: 289.6,345.2		0.092Å--
A 326 LYS45.050.558Å
CG with A 320 ALA HB1 		Favored (83.46%)
General case / -67.1,-43.1		84% (mttt)
chi angles: 283.3,178.2,168.7,166.5		0.059Å--
A 327 LEU40.43-Favored (56.25%)
General case / -68.2,-50.1		52.1% (tp)
chi angles: 181.6,58.4		0.023Å--
A 328 LYS48.81-Favored (68.93%)
General case / -56.9,-35.3		31.7% (mmtt)
chi angles: 279.8,295.4,155.7,197.9		0.015Å--
A 329 ALA39.05-Favored (86.49%)
General case / -62.5,-46.9		-0.024Å--
A 330 SER41.64-Favored (72.5%)
General case / -65.7,-31.5		0%
chi angles: 119.2		0.055Å--
A 331 GLN40.58-Favored (67.26%)
General case / -72.9,-36.5		99.1% (mt-30)
chi angles: 293.3,179,332.1		0.026Å--
A 332 ALA37.11-Favored (95.31%)
General case / -62.8,-44.8		-0.061Å--
A 333 ARG56.75-Favored (80.61%)
General case / -67.9,-36.7		14.6% (ttm105)
chi angles: 198.8,197,280.9,93.6		0.043Å--
A 334 ASP37.970.458Å
OD2 with A 338 LYS HE2 		Favored (84.89%)
General case / -59.5,-47.6		38.6% (t70)
chi angles: 185.1,58.5		0.076Å--
A 335 LEU37.64-Favored (97.3%)
General case / -62.5,-44.1		33.7% (tp)
chi angles: 184.9,55.1		0.02Å--
A 336 LEU40.60.512Å
HD13 with A 313 PHE CE2 		Favored (74.41%)
General case / -55.1,-48.0		7.7% (mt)
chi angles: 263.2,175.6		0.064Å--
A 337 SER34.970.439Å
HA with A 309 PHE CE2 		Favored (62.11%)
General case / -59.1,-23.4		52.8% (p)
chi angles: 74.7		0.028Å--
A 338 LYS40.650.458Å
HE2 with A 334 ASP OD2 		Favored (23.05%)
General case / -93.5,-17.8		48.8% (mttm)
chi angles: 293.4,175.7,189.1,318.9		0.031Å--
A 339 MET39.13-Favored (11.23%)
General case / -94.6,-37.6		71.2% (mtm)
chi angles: 294,189.6,299.7		0.023Å--
A 340 LEU37.31-Favored (8.05%)
General case / -87.6,64.4		75.8% (mt)
chi angles: 289.3,177		0.032Å--
A 341 VAL40.62-Favored (64.66%)
Isoleucine or valine / -120.7,121.2		71.5% (t)
chi angles: 173.3		0.094Å--
A 342 ILE41.87-Favored (91.89%)
Isoleucine or valine / -58.9,-45.0		76.9% (mt)
chi angles: 302.3,173.1		0.05Å--
A 343 ASP48.89-Favored (61.12%)
Pre-proline / -80.4,116.3		63.1% (t0)
chi angles: 179.7,173.7		0.045Å--
A 344 PRO42.51-Favored (57.76%)
Trans proline / -64.4,-16.9		27.3% (Cg_endo)
chi angles: 20.5,323.7,157.6		0.1Å--
A 345 ALA44.66-Favored (61.57%)
General case / -73.3,-27.4		-0.055Å--
A 346 LYS54.570.548Å
NZ with A 283 CYS SG 		Favored (26.62%)
General case / -106.9,3.7		28.4% (mtmm)
chi angles: 295.1,183.8,279.3,277.8		0.02Å--
A 347 ARG41.14-Favored (31.23%)
General case / -89.1,138.7		31.6% (ttm180)
chi angles: 182.2,190,309.2,152.4		0.063Å--
A 348 ILE420.409Å
HG12 with A 349 SER N 		Favored (2.3%)
Isoleucine or valine / -58.6,156.0		13.3% (tt)
chi angles: 184.4,178.1		0.035Å--
A 349 SER41.720.409Å
N with A 348 ILE HG12 		Favored (9.89%)
General case / -96.1,169.6		79.2% (p)
chi angles: 70		0.101Å--
A 350 VAL38.620.577Å
HA with A 246 ILE HD11 		Favored (97.19%)
Isoleucine or valine / -60.8,-45.8		72.6% (t)
chi angles: 173.2		0.039Å--
A 351 ASP46.6-Favored (80.06%)
General case / -63.5,-35.3		72.1% (m-20)
chi angles: 289.3,141.7		0.051Å--
A 352 ASP44.55-Favored (60.97%)
General case / -75.4,-33.0		93.8% (m-20)
chi angles: 290.6,157.8		0.058Å--
A 353 ALA39.65-Favored (80.86%)
General case / -65.6,-35.5		-0.027Å--
A 354 LEU41.79-Favored (63.65%)
General case / -69.6,-19.0		29.8% (mt)
chi angles: 286.3,159.3		0.006Å--
A 355 GLN56.67-Favored (38.33%)
General case / -93.4,-9.5		14.9% (mm-40)
chi angles: 288.7,284.8,55.7		0.132Å--
A 356 HIS43.060.522Å
O with A 360 ASN HB2 		Favored (92.46%)
Pre-proline / -68.5,140.7		66.1% (t-80)
chi angles: 192.4,285.9		0.065Å--
A 357 PRO41.520.42Å
HD2 with A 356 HIS ND1 		Favored (70.37%)
Trans proline / -53.4,-34.2		54.1% (Cg_exo)
chi angles: 334.6,40.2,81.3		0.035Å--
A 358 TYR39.55-Favored (80.33%)
General case / -65.1,-35.2		33.1% (t80)
chi angles: 193.4,65.9		0.033Å--
A 359 ILE42.4-Favored (13.09%)
Isoleucine or valine / -94.8,-43.6		19.8% (mm)
chi angles: 297.9,313.1		0.06Å--
A 360 ASN57.670.522Å
HB2 with A 356 HIS O 		Allowed (0.11%)
General case / -37.6,-34.7		3.8% (t-20)
chi angles: 220,358.6		0.014Å--
A 361 VAL48.54-Allowed (1.77%)
Isoleucine or valine / -64.3,-4.9		4.1% (m)
chi angles: 312.4		0.041Å--
A 362 TRP48.870.474Å
CZ2 with A 164 GLU HG2 		Favored (12.43%)
General case / -110.4,-21.0		86.3% (m95)
chi angles: 299.4,112.2		0.023Å--
A 363 TYR53.44-Allowed (0.24%)
General case / -32.0,127.1		15.3% (t80)
chi angles: 200.8,95		0.062Å--
A 364 ASP59.54-Favored (6.64%)
Pre-proline / -142.8,118.3		54.9% (t0)
chi angles: 186.3,158.3		0.038Å--
A 365 PRO60.16-Favored (69.59%)
Trans proline / -52.0,-38.6		21.4% (Cg_exo)
chi angles: 324.3,46.2,81.2		0.037Å--
A 366 ALA61.04-Favored (65.7%)
General case / -67.3,-23.8		-0.025Å--
A 367 GLU61.43-Favored (11.8%)
General case / -98.3,-31.9		53.8% (mt-10)
chi angles: 308.2,171.6,140.6		0.025Å--
A 368 VAL64.12-Favored (5.28%)
Isoleucine or valine / -88.7,-29.4		55.4% (t)
chi angles: 169.7		0.045Å--
A 369 GLU72.89-Favored (7.11%)
General case / -117.8,30.7		15.2% (mt-10)
chi angles: 295.2,152,61.2		0.022Å--
A 370 ALA72.19-Favored (69.37%)
Pre-proline / -58.3,146.9		-0.036Å--
A 371 PRO77.260.457Å
O with A 373 PRO HD3 		Favored (3.01%)
Trans proline / -54.0,116.4		88.4% (Cg_exo)
chi angles: 331.4,43.8,78.1		0.007Å--
A 372 PRO79.220.401Å
HD3 with A 371 PRO HA 		Allowed (1.73%)
Trans proline / -68.7,107.8		87.6% (Cg_exo)
chi angles: 331.3,43.6,78.7		0.052Å--
A 373 PRO80.450.489Å
HD3 with A 179 HIS CE1 		Favored (74.9%)
Trans proline / -66.2,144.4		75.1% (Cg_exo)
chi angles: 333.1,44,76.6		0.037Å--
A 374 GLN80.62---0.021Å--
A 379 GLN84.61---0.01Å--
A 380 LEU84.460.547Å
HD12 with A 380 LEU N 		Favored (20.95%)
General case / -129.6,117.8		0.3%
chi angles: 321.5,79.6		0.038Å--
A 381 ASP87.02-Favored (4.75%)
General case / -173.4,165.9		24% (t0)
chi angles: 183.6,41.1		0.028Å--
A 382 GLU84.5-OUTLIER (0.01%)
General case / 52.0,100.8		-0.008Å--
A 383 ARG82.38-OUTLIER (0.05%)
General case / 178.4,123.9		-0.043Å--
A 384 GLU79.29-Favored (44.26%)
General case / -71.3,151.3		6.9% (pt-20)
chi angles: 84.1,179.9,66		0.041Å--
A 385 HIS72.15-Favored (31.2%)
General case / -155.9,154.4		44.4% (m-70)
chi angles: 278.7,301.3		0.043Å--
A 386 THR64.33-Favored (12.2%)
General case / -87.8,169.3		35% (p)
chi angles: 52.3		0.063Å--
A 387 ILE58.96-Favored (12.01%)
Isoleucine or valine / -51.1,-54.1		73.3% (mt)
chi angles: 299.8,177.3		0.085Å--
A 388 GLU59.71-Favored (74.95%)
General case / -55.5,-42.9		0%
chi angles: 12,146.8,64.3		0.042Å--
A 389 GLU57.91-Favored (77.65%)
General case / -68.7,-42.5		53% (mt-10)
chi angles: 298,162.9,139.8		0.012Å--
A 390 TRP46.8-Favored (97.45%)
General case / -61.8,-41.2		7.5% (m95)
chi angles: 276.2,130.2		0.084Å--
A 391 LYS51.59-Favored (89.54%)
General case / -60.0,-46.4		86.2% (tttt)
chi angles: 188.1,179.3,179.8,182.3		0.047Å--
A 392 GLU58.670.449Å
HG2 with A 396 LYS HE3 		Favored (75.17%)
General case / -70.2,-37.8		30.3% (tt0)
chi angles: 193.7,172.9,119.2		0.016Å--
A 393 LEU49.52-Favored (98.62%)
General case / -62.7,-43.5		32% (mt)
chi angles: 280.1,171.2		0.009Å--
A 394 ILE48.96-Favored (66.94%)
Isoleucine or valine / -72.1,-43.4		93.5% (mt)
chi angles: 292.2,171.3		0.042Å--
A 395 TYR56.83-Favored (77.23%)
General case / -58.8,-37.8		75.6% (t80)
chi angles: 179.6,69		0.055Å--
A 396 LYS63.230.449Å
HE3 with A 392 GLU HG2 		Favored (77.22%)
General case / -69.3,-41.1		95.9% (mttt)
chi angles: 288.1,178.4,178.2,171.8		0.039Å--
A 397 GLU63.24-Favored (98.6%)
General case / -61.7,-43.6		8.1% (tp10)
chi angles: 203.6,58.3,65.6		0.031Å--
A 398 VAL60.14-Favored (62.79%)
Isoleucine or valine / -62.0,-52.2		55.1% (t)
chi angles: 169.8		0.017Å--
A 399 MET67.16-Favored (70.72%)
General case / -68.0,-31.2		32.7% (mmt)
chi angles: 291.2,299.9,90.7		0.042Å--
A 400 ASN70.58--3.1% (t-20)
chi angles: 224.8,347.7		0.066Å--
A 502 ANP54.10.52Å
H5'2 with A 226 THR OG1 		-----
A 501 88045.45------
A 601 HOH35.61------
A 602 HOH29.22------
A 603 HOH40------
A 604 HOH34.53------
A 605 HOH38.38------
A 606 HOH38.69------
A 607 HOH36.18------
A 608 HOH35.29------
A 609 HOH33.03------
A 610 HOH36.82------
A 611 HOH42.92------
A 612 HOH39.73------
A 613 HOH35.790.442Å
O with A 192 PRO HD2 		-----
A 614 HOH41.51------
A 615 HOH36.29------
A 616 HOH40.71------
A 617 HOH48.88------
A 619 HOH43.48------
A 621 HOH45.29------
A 622 HOH48.63------
A 623 HOH43.42------
A 624 HOH49.810.588Å
O with A 147 GLU HG2 		-----
A 625 HOH34.28------
A 626 HOH40.69------
A 627 HOH40.74------
A 628 HOH50.55------
A 629 HOH42.040.41Å
O with A 125 SER HB2 		-----
A 631 HOH42.5------
A 632 HOH43.1------
A 633 HOH48.09------
A 634 HOH48.2------
A 639 HOH36.66------
A 640 HOH43.36------
A 641 HOH40.6------
A 642 HOH49.78------
A 646 HOH44.11------
A 647 HOH41.02------
A 648 HOH46.63------
A 649 HOH53.6------
A 651 HOH47.7------
A 654 HOH43.94------
A 655 HOH43.51------
A 656 HOH50.34------
A 658 HOH41.71------
A 659 HOH51.54------
A 663 HOH48.83------
A 664 HOH50.8------
A 665 HOH45.42------
A 669 HOH52.31------
A 671 HOH49.74------
A 677 HOH49.39------
A 680 HOH46.23------
A 681 HOH54.55------
A 682 HOH54.81------